Industry symposia

The IDF World Diabetes Congress 2025 features 130 hours of scientific sessions, with more than 250 international speakers including some of the top experts in diabetes today.

Industry symposia are an integral part of the congress programme, offering high-quality content and high-level speakers.

Companies operating in the field of diabetes value IDF Congresses as relevant and impactful opportunities to present the latest research and share innovative products with an international audience of health professionals.

Browse the full industry symposia programme below.

All times ICT (UTC+7).

Monday, 7 April
10:00-11:45
Silk 1

Diabetes India Satellite Symposium

Programme

Chairs: Dr Ashok Kumar Das, Dr Abhay Sahoo
Type 2 Diabetes in India: State of the Nation
Dr. A K Das
Unholy Trinity of Sugar, Salt, and Butter in Metabolic Syndrome
Dr. Hemant P Thacker

FDCs - Made in India: Paving The Path Towards Improved Global Glycemic Care
Dr. Purvi Chawla

Programme

Comprehensive Management of Type 2 Diabetes Using Blue Index, a Motivational Diabetes Scores
Dr. Sanjeev Pathak

Evolution of Glycemic Monitoring and What the Future Promises us
Dr. Jayant Panda

Future of Telemedicine & Remote Diabetes Management
Dr. Bharat Saboo

Revolutionising AI-powered screening for Diabetic Retinopathy, AMD and Glaucoma
Dr. Bhavana Sosale

Monday, 7 April
12:00-14:00
Nile 1

Abbott Libre Academy: Revolutionizing Diabetes Care | CGM Essentials to Unlocking Progress

Programme

Chair: Deerochanawong, Chaicharn
Beyond HbA1c: Enhancing Diabetes Care with CGM

Enhancing Clinical Outcomes with CGM: Evidence and Insights

Overview of CGM Guidelines and Consensus

The Essentials of Glucose Monitoring: FreeStyle Libre

Integrating FreeStyle Libre into Clinical Workflow: Reports and Interpretation

Programme

Question and Answers and Closing Remarks

Speakers: Hussain, Syed Sufyan (United Kingdom) & Mader, Julia (Austria)

Monday, 7 April
12:15-14:00
Silk 1

DASG Satellite Symposium

Programme

Chairpersons: Dr. Juliana Chan (Hong Kong), Dr. Asher Fawwad (Pakistan)
Subtyping Diabetes in Asians
Dr. Daphne Gardner (Singapore)

Heterogeneity of Young Onset Diabetes
Dr. Juliana Chan (Hong Kong)

Is there a Gender Difference of Heart & Kidney Complications in People with Diabetes?
Dr. Lee Ling Lim (Malaysia)

Programme

Inflammation in Pathogenesis of Diabetes and it’s Complications
Dr. Daphne Gardner (Singapore)

A Framework to Combat Growing Epidemic of Young-Onset Type 2 Diabetes in Asia
Dr. Rakesh Parikh (India)

Panel Discussion: Challenges and Innovations in Diabetes Management
Moderated by: Dr. Asher Fawwad (Pakistan)

Monday, 7 April
14:30-16:30
Silk 1

Diabetes in Asia: Understanding Risk, Environment, and Innovative Management Strategies in China and Beyond

Programme

Disease burden of obesity and related chronic diseases in China and intervention efforts
Youfa Wang

Trends in prevalence of diabetes, related management, and risk factors in China
Limin Wang

Regional and ethnic disparities in obesity and related non-communicable diseases in China
Wen Peng

Diabetes Self-management in the Digital Age: Digital and Intelligent Diabetes Shared-care Management Beijing Model
Junqing Zhang

Programme

Practices of prevention and treatment of diabetes in China
Juhong Yang

Diabetes prevention and treatment in East Asia- emerging trends and future directions
Ronald Ma

Tuesday, 8 April
12:30-13:30
Amber

Shape the future of Nerve Health - Empower the patient

Programme

Welcome and introduction

Diabetic Neuropathy: Can we do better?
Prof Rayaz Malik (Qatar)

The new ACT tool – empowering the patient to act
Dr. Hoda Gad (Qatar)

Validation of the ACT Tool in Latin America: Ecuador Pilot
Dr. C. Solis. Sanchez (Ecuador)

Solving the puzzle of diabetic peripheral neuropathy
Panel discussion, international expert panel

Tuesday, 8 April
12:30-13:30
Grand Hall 201

Implementing MNT in diabetes management: Time to move the needle

Programme

Chair: Dr. Jose Rodolfo Dimaano Jr
12h30 – 13h10: Panel discussion
Welcome and introduction
Moderator led Q&A discussion with the panel of experts

Expert Panellists:
Prof V Mohan (India)
Prof Winnie Chee (Malaysia)
Prof Chaicharn Deerochanawong (Thailand)

Programme

13h10-13h25: Translating the latest evidence of MNT in diabetes management
Prof Siew Ling Tey (Singapore)

13h25-13h30: Concluding
Summary of the session proceedings and discussion
Moderator: Dr. Jose Rodolfo Dimaano Jr (the Philippines)

Tuesday, 8 April
12:30-13:30
Grand Hall 202

Optimizing Care in Heart Failure, Chronic Kidney Disease and Diabetes with non-steroidal MRAs

Programme

Chairs: Linong Ji (China), Alice Cheng (Canada)
Welcome and introduction

Kidney disease in Type 1 and Type 2 Diabetes: Bridging the gaps
Per-Henrik Groop (Finland)

New paths to improve outcomes in heart failure
John McMurray (UK)

Programme

Non-steroidal MRAs in cardiovascular, kidney, and diabetes care: practical considerations
Luc van Gaal (Belgium)

Discussion & Closure
Alice Cheng (Canada)

Organized by Sciarc, kindly supported by Bayer AG.

Tuesday, 8 April
12:30-13:30
Nile 1

New insights into treatment of Type 2 diabetes

Programme

Chair: Lynch, Amber

Is progression of β-cell dysfunction in Type 2 diabetes inevitable?
Hussain, Sufyan

GIP and GLP-1 receptor agonist mechanism of action in Type 2 diabetes
Rachman, Jonathan

Panel Question and Answer

Programme

Panel discussion
WHO PQ or Regional Offices, Life for A Child, Action for Diabetes, EVA Pharma, Egypt MOH.)

Question & Answer

Tuesday, 8 April
12:30-13:30
Nile 2

The Beauty and Opportunity of Breath Ketone to Transform Diabetes Care

Programme

Welcoming remarks and brief introduction
Dr Christine Yip, CEO & Founder of AusMed Global (China)

Ketone measurements in diabetes management
Prof Lee Chi Ho Paul (Hong Kong)

The Synergy of digital twin technology and breath ketone measurement for diabetes care
Prof Joe Dong (Hong Kong)

Programme

Efficacy and safety of GLP1Ra combination therapy: a population-based cohort study
Prof Gary Tse (Hong Kong)

Question & Answers
Dr Christine Yip and faculty

Tuesday, 8 April
17:30-19:30
Nile 2

Global Health session “How Private Sector Can Help Improve Access to Health Care: A Case of Lilly”

Programme

Opening remarks
Dr Robert Heine, USA and Prof. Peter Schwarz, Germany

Barriers to health care access
Adilet-Sultan Meimanaliev, USA
Strategic collaborations to expand access to medicines in low- and middle-income countries
Dr Sylvia Vito, Kenya and Rob Lloyd, USA

Programme

Strategic collaborations to advance access to type 1 diabetes care in low- and middle-income countries
Dr Graham Ogle, Australia and Fiona Ooi, A4D, Malaysia

Panel discussion and Q&A

Tuesday, 8 April
12:30-13:30
Silk 1

Assessing and addressing needs in T2D for glycemic control, cardiorenal protection and adherence: What are our options?

Programme

Chair: Kamlesh Khunti (UK)
Introduction

Glycaemic control and Cardiorenal benefits: Together or one over the other?
Ashwani Mehta (India), Juliana Chan (Hong Kong)

The paramount importance of Glycaemic control: What are our options?
Mohamed M Hassanein (UAE)

Programme

Simplifying adherence for people with type 2 diabetes: What are the unmet needs ?
Somia Iqtadar (Pakistan), Narsimha Raju Dichpally (India)

Discussion

Tuesday, 8 April
17:30-19:30
Silk 2

From Namaste to Sawasdee: A night of continuous connection

Programme

Chair: Lee, Kenneth (Singapore)

From Data to Decisions: Leveraging CGM for Clinical Excellence
Prof. Satish Garg (USA)

From BGM to CGM: Enhancing Diabetes Care In India with Cost-Effective Monitoring
Mohan, Viswanathan (India)

Speed Networking: Ignite Continuous Connections
All faculty

Tuesday, 8 April
12:30-13:30
Meeting Room 216

Bridging gaps: Integrated strategies to address TB and Diabetes

Programme

Overview of burden and latest WHO guidance to address TB and Diabetes
Baddeley, Annabel (Switzerland)

Impact and feasibility of integrated TB and Diabetes care - synthesis of the evidence and research gaps
Nyirenda, John L.Z. (Germany)

Panel discussion - Scaling up collaborative action on TB and diabetes - challenges, opportunities, and what will it take?
People with lived experience of TB and diabetes

Tuesday, 8 April
12:30-13:30
Diabetes Spotlight

Redefining insulin access: a framework for equity and innovation

Programme

Moderator
Ms Nupur Lalvani Blue Circle Voice member living with type 1 diabetes

Welcome
Prof Peter Schwarz, IDF President

The challenges of the insulin market
Ms Molly Lepeska, ACCISS Study Project Manager, Health Action International

The WHO Global Diabetes Compact’s potential to improve access to insulin
Dr Guy Fones, WHO acting Director NCD department

Programme

The insulin market challenges: three country cases
Ms Nupur Lalvani, moderator, Ms Osarenkhoe Ethel Chima-Nwogwugwu, Blue Circle Voice, Nigeria, Mr Mohammed Seyam, Young Leader in Diabetes, Palestine
The IHMF: what is it, why has it been developed, and what are its aims
Mr Ulrik Uldall Nielsen, Novo Nordisk, Global Health Equity Lead
Mentimeter with the audience: do you think that a tool like the IHMF could have the capacity to improve access to insulin in your country?
Ms Nupur Lalvani
Q&A
Closing remarks

Tuesday, 8 April
17:30-19:30
Nile 1

The time is now: improving access to diabetes care in a strengthened global policy framework
Programme
Introductory remarks
IDF President-elect and Dr Anil Kapur, WDF Board Chairman
Keynote intervention
Dr Guy Fones, Director a.i, WHO Noncommunicable Diseases, Rehabilitation and Disability (NCD)
Keynote intervention
Ms Anita Sabidi, Blue Circle Voices member

Programme
Panel 1 – Implementing diabetes programmes as part of the national NCD strategy
Dr Nilufar Ibragimova, Dr Silvia Lapertosa, Ms Rachel Nungu, and Ms Nurianne Arias
Panel 2 – The Global Diabetes Compact as a unifying dynamic
Prof Abdul Basit, Ms Lucia Feito Allonca, Ms Osarenkhoe Ethel Chima-Nwogwugwu, Prof Alicia Jenkins
Reflections and plenary debate
Dr Guy Fones, Dr Jackie Maalouf, and Dr Anil Kapur

Wednesday, 9 April
12:30-13:30
Amber

Holistic and connected diabetes management: Insights from the patient’s perspective
Programme
Chair: Abdul Basit (Pakistan)
The transformative impact of emotional support and education of digital diabetes technology - Juliana Chan (Hong Kong)
Empowering patients through blood glucose monitoring: Fostering ownership and enhancing lifestyle behaviors - Jothydev Kesavadev (India).
Collaboration in action: Bridging healthcare support and patient-driven decisions in diabetes management - Nitchakarn Laichuthai (Thailand)

Wednesday, 9 April
12:30-13:30
Diabetes spotlight

Breaking Barriers in Peripheral Neuropathy Management– From Silent Suffering to Superior Treatment
Programme
Chair: Dr. LI Yan (Singapore)
One-stop-shop diagnosis of Diabetic Complications and Diabetic Peripheral Neuropathy
Dr. Dela Pena Pepito (the Philippines)
Role of High-Dose Neurotropic B vitamins in the management of Peripheral Neuropathy
Dr. Pinzon Rizaldy Taslim (Indonesia)

Programme
Safe use of vitamin B6 in management of Peripheral Neuropathy
Prof Kongkiat Kulkantrakorn (Thailand)

Wednesday, 9 April
17:30-18:30
Grand Hall 201

4th WHO Global Diabetes Compact anniversary: Achieving five diabetes targets in five years: Is integration to PHC/UHC the key?
Programme
Remarks from the perspective of a person living with diabetes
Heather Koga, Member, IDF Blue Circle Voices
WHO Global Diabetes Compact: Four years of progress
Dr Guy Fones, Director a.i., Department of Noncommunicable Diseases, Rehabilitation and Disability, WHO HQ
IDF remarks: Achieving global diabetes targets in five years (2030)
Prof Peter Schwarz, President, IDF
Programme
Panel Discussion on Integrating Diabetes into PHC/UHC
Panellists: Heather Koga, Dr Krisada Hanbunjerd, Dr Nikhil Tandon, Chair, Leif Fenger Jensen
Moderator: Dr Guy Fones
Q&A with the audience
Closing remarks

Wednesday, 9 April
12:30-13:30
Grand Hall 202

Revolutionizing Diabetes Care with CGM: Innovation for Accessibility and Ease
Programme
Opening and Introduction
CGM as the Standard of Care
Prof. Satish Garg (USA)
CGM to Elevate Quality of Life
Prof. Alice Cheng (Canada)
CGM Access for All?
Dr. Viswanathan Mohan (India)
Q&A and Closing
All faculty

Wednesday, 9 April
12:30-13:30
Nile 1

CME Session: Seeing Beyond the Numbers in Type 2 Diabetes: Empowering Patients for Optimal Weight and Glycaemic Management
Programme
Chair: Prof. Melanie Davies (UK)
Introduction: Challenges in Weight and Glycaemic Management
Following the Patients’ Journeys
- Integrating Weight and Glycaemic Management: Overcoming Clinical Inertia and Barriers to Effective Treatment
- Utilising Shared Decision-Making in Treatment Choices
- Incorporating Multidisciplinary Team Approaches
Symposium Summary and Q&A

Programme
This CME activity is provided by PVI, PeerView Institute for Medical Education, and supported by an educational grant from Lilly.

Wednesday, 9 April
17:30-19:00
Nile 2

Unlocking Innovation in Diabetes & Metabolic Health
Programme
Welcome and introduction
Dr Mangesh Tiwaskar
President Address
Dr Jyotirmoy Pal
Type 2 diabetes phenotypes and clusters – Evolving science
Dr Shashank Joshi
How technology is “tech-ing” on type 1 diabetes: case-based perspectives
Dr Banshi Saboo

Programme
Role of Adiposity in Diabetes Management
Dr Sanjay Agarwal
Panel Discussion
Dr Agam Vora and Panelists
Prevalence and Disease Burden of Diabetic Peripheral Neuropathy in India- Epidemiological Insights
Dr V. Mohan
Thank you
Dr Agam Vora

Wednesday, 9 April
12:30-13:30
Silk 1

Metformin and Insulin Resistance: Bridging Science and Clinical Practice
Programme
Welcome and introduction
Chaicharn Deerochanawong (Thailand)
Metformin in early and impending diabetes
Nemencio Nicodemus (the Philippines)
Metformin in PCOS
Anju Joham (Australia)
Metformin during pregnancy
Dittakarn Boriboonhirunsarn (Thailand)

Wednesday, 9 April
12:30-13:30
Silk 2

Early Combinational Therapy of DPP-4i Plus SGLT2i: Patient Profile, Approaches, Strategies, Guidelines, and Pitfalls
Programme
Chairperson: Dr. Apichati Vichayanrat
Welcome and Opening Remarks
Keynote Lecture: “Early Combinational Therapy of DPP-4i Plus SGLT2i”
Prof. Peter Schwarz
_Rationale for early combination therapy.
_Patient profiles suitable for DPP-4i and SGLT2i combination.
_Clinical approaches and strategies.
_Current guidelines and evidence-based recommendations.
_Common pitfalls and how to avoid them.
Programme
Questions and Answers
Moderator: Dr. Apichati Vichayanrat
Speaker: Prof. Peter Schwarz
Closing Remarks and Summary
Dr. Apichati Vichayanrat

Thursday, 10 April
12:30-13:30
Silk 2

Life for a Child Program update, including analogue insulin studies with partners